Biotechnological Approaches to Fight Pathogens at Mucosal Sites
- 1 July 2001
- journal article
- review article
- Published by Taylor & Francis in Biotechnology and Genetic Engineering Reviews
- Vol. 18 (1) , 329-347
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Protection against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective AntibodyInfection and Immunity, 2000
- Immunogenicity of the B Monomer ofEscherichia coliHeat-Labile Toxin Expressed on the Surface ofStreptococcus gordoniiInfection and Immunity, 2000
- Passive immunity against rotavirus in infantsActa Paediatrica, 1999
- The HIV-Inactivating Protein, Cyanovirin-N, Does Not Block gp120-Mediated Virus-to-Cell BindingBiochemical and Biophysical Research Communications, 1998
- Solution structure of cyanovirin-N, a potent HIV-inactivating proteinNature Structural & Molecular Biology, 1998
- Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine designJournal of Molecular Biology, 1997
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- A host-vector system for heterologous gene expression in Streptococcus gordoniiGene, 1996
- Boost for vaginal microbicides against HIVThe Lancet, 1993
- Production of antibodies in transgenic plantsNature, 1989